1. Home
  2. DVA vs CRDO Comparison

DVA vs CRDO Comparison

Compare DVA & CRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • CRDO
  • Stock Information
  • Founded
  • DVA 1994
  • CRDO 2008
  • Country
  • DVA United States
  • CRDO Cayman Islands
  • Employees
  • DVA N/A
  • CRDO N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • CRDO Semiconductors
  • Sector
  • DVA Health Care
  • CRDO Technology
  • Exchange
  • DVA Nasdaq
  • CRDO Nasdaq
  • Market Cap
  • DVA 12.6B
  • CRDO 11.6B
  • IPO Year
  • DVA 1995
  • CRDO 2022
  • Fundamental
  • Price
  • DVA $173.05
  • CRDO $58.15
  • Analyst Decision
  • DVA Hold
  • CRDO Strong Buy
  • Analyst Count
  • DVA 5
  • CRDO 10
  • Target Price
  • DVA $153.40
  • CRDO $72.90
  • AVG Volume (30 Days)
  • DVA 533.7K
  • CRDO 5.0M
  • Earning Date
  • DVA 02-11-2025
  • CRDO 02-25-2025
  • Dividend Yield
  • DVA N/A
  • CRDO N/A
  • EPS Growth
  • DVA 41.03
  • CRDO N/A
  • EPS
  • DVA 9.24
  • CRDO N/A
  • Revenue
  • DVA $12,666,614,000.00
  • CRDO $245,588,000.00
  • Revenue This Year
  • DVA $6.18
  • CRDO $105.88
  • Revenue Next Year
  • DVA $3.58
  • CRDO $55.80
  • P/E Ratio
  • DVA $18.74
  • CRDO N/A
  • Revenue Growth
  • DVA 6.34
  • CRDO 48.40
  • 52 Week Low
  • DVA $107.44
  • CRDO $16.82
  • 52 Week High
  • DVA $178.75
  • CRDO $86.69
  • Technical
  • Relative Strength Index (RSI)
  • DVA 70.13
  • CRDO 38.22
  • Support Level
  • DVA $167.57
  • CRDO $51.80
  • Resistance Level
  • DVA $170.80
  • CRDO $86.69
  • Average True Range (ATR)
  • DVA 3.66
  • CRDO 5.76
  • MACD
  • DVA 1.75
  • CRDO -2.31
  • Stochastic Oscillator
  • DVA 79.39
  • CRDO 18.20

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business.

About CRDO Credo Technology Group Holding Ltd

Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.

Share on Social Networks: